Cardlytics Inc (NASDAQ: CDLX) is -77.19% lower on its value in year-to-date trading and has touched a low of $1.22 and a high of $9.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDLX stock was last observed hovering at around $1.68 in the last trading session, with the day’s gains setting it 0.35%.
Currently trading at $2.03, the stock is 16.43% and 12.17% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.38 million and changing 20.83% at the moment leaves the stock -25.94% off its SMA200. CDLX registered -45.28% loss for a year compared to 6-month loss of -33.66%. The firm has a 50-day simple moving average (SMA 50) of $1.8123 and a 200-day simple moving average (SMA200) of $2.74675.
The stock witnessed a 13.41% gain in the last 1 month and extending the period to 3 months gives it a 35.33%, and is 13.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.63% over the week and 9.17% over the month.
Cardlytics Inc (CDLX) has around 454 employees, a market worth around $106.58M and $272.59M in sales. Profit margin for the company is -65.41%. Distance from 52-week low is 66.39% and -78.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.17%).
with sales reaching $64.06M over the same period.The EPS is expected to grow by 68.61% this year, but quarterly earnings will post -2.78% year-over-year. Quarterly sales are estimated to shrink -8.01% in year-over-year returns.
Cardlytics Inc (CDLX) Top Institutional Holders
150.0 institutions hold shares in Cardlytics Inc (CDLX), with institutional investors hold 56.45% of the company’s shares. The shares outstanding are 52.17M, and float is at 49.77M with Short Float at 14.95%. Institutions hold 54.93% of the Float.
The top institutional shareholder in the company is CAS INVESTMENT PARTNERS, LLC with over 6.46 million shares valued at $53.08 million. The investor’s holdings represent 13.1785% of the CDLX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.15 million shares valued at $25.88 million to account for 6.4248 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.41 million shares representing 4.9179% and valued at over $19.81 million, while MORGAN STANLEY holds 4.4152 of the shares totaling 2.17 million with a market value of $17.78 million.
Cardlytics Inc (CDLX) Insider Activity
The most recent transaction is an insider sale by Gupta Amit,the company’sChief Executive Officer. SEC filings show that Gupta Amit sold 6,725 shares of the company’s common stock on Jul 02 ’25 at a price of $1.78 per share for a total of $11988.0. Following the sale, the insider now owns 0.38 million shares.
Cardlytics Inc disclosed in a document filed with the SEC on Jul 02 ’25 that DeSieno Alexis (Chief Financial Officer) sold a total of 7,324 shares of the company’s common stock. The trade occurred on Jul 02 ’25 and was made at $1.78 per share for $13056.0. Following the transaction, the insider now directly holds 0.17 million shares of the CDLX stock.
Still, SEC filings show that on Jul 02 ’25, Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) disposed off 5,271 shares at an average price of $1.78 for $9396.0. The insider now directly holds 109,636 shares of Cardlytics Inc (CDLX).
